Arecor and Sequel Med Tech to Host Virtual Panel on Future of Diabetes Treatment

Arecor Therapeutics PLC ( (GB:AREC) ) just unveiled an announcement.

Arecor Therapeutics has announced that it will co-host a virtual fireside panel discussion with Sequel Med Tech on 7 January 2026 to explore the future of the treatment journey for people with diabetes and the factors driving innovation in diabetes care. The event, which will not introduce any new material company information, underscores Arecor’s and Sequel’s strategic focus on advanced insulin and drug-delivery technologies and positions both companies as thought leaders in shaping next-generation diabetes management solutions for patients and healthcare stakeholders.

The most recent analyst rating on (GB:AREC) stock is a Hold with a £76.00 price target. To see the full list of analyst forecasts on Arecor Therapeutics PLC stock, see the GB:AREC Stock Forecast page.

Spark’s Take on GB:AREC Stock

According to Spark, TipRanks’ AI Analyst, GB:AREC is a Neutral.

Arecor Therapeutics’ score is driven by positive corporate events, including strategic partnerships and IP expansion, which bolster its market position. However, financial performance challenges, such as ongoing losses and cash flow issues, weigh heavily on the overall score. Technical analysis and valuation present a neutral outlook, reflecting the typical risks and opportunities in the biotech sector.

To see Spark’s full report on GB:AREC stock, click here.

More about Arecor Therapeutics PLC

Arecor Therapeutics plc is a Cambridge, UK-based clinical-stage biopharmaceutical company focused on drug development and delivery in diabetes and other cardiometabolic diseases. Using its proprietary Arestat technology platform, the company is advancing a portfolio of proprietary products and partnered programmes, led by AT278, an ultra-concentrated (500U/mL) ultra-rapid-acting insulin, and is also developing an oral delivery platform for peptide drugs such as GLP-1 receptor agonists targeting the obesity and diabetes markets.

Average Trading Volume: 41,966

Technical Sentiment Signal: Buy

Current Market Cap: £32.09M

See more data about AREC stock on TipRanks’ Stock Analysis page.